Cardiac pacemakers and implantable cardioverter defibrillators (ICDs), which are often implanted into patients with such heart conditions, impair the utility of LGE MRI by producing disruptive imaging artifacts. These artifacts manifest as bright contrast signals, image distortions, or signal voids. Combined, these artifacts drastically limit a physician’s ability to determine if scar tissue is present. Given that over 500,000 patients are implanted with ICDs or pacemakers every year in the U.S., the inability to have diagnostic LGE MRI imaging for these patients represents a significant hazard and unmet need. Thus, novel methods or approaches are needed to clarify LGE MRI images for these at-risk patient populations.
Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 11,709,216 | 07/25/2023 | 2013-310 |
United States Of America | Issued Patent | 10,649,053 | 05/12/2020 | 2013-310 |
European Patent Office | Published Application | 2914172 | 08/07/2015 | 2013-310 |
Late gadolinium enhancement, LGE, magnetic resonance imaging, MRI, pacemaker, cardiac, implantable cardioverter defibrillators, ICD, ischemic heart disease, myocarditis, cardiomyopathy, sarcoidosis, arrhythmia, arrhythmogenic right ventricular dysplasia,, amyloidosis, myocardial disease, ventricular tachycardia, imaging, scar tissue